Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Gevokizumab

EU orphan designation number: EU/3/13/1111   
Active ingredient: Gevokizumab
Indication: Treatment of chronic non-infectious uveitis
Sponsor: XOMA UK Limited
c/o Arnold & Porter (UK) LLP, Tower 42, 25 Old Broad Street, London EC2N 1HQ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/03/2013 Orphan designation EMA/OD/161/12 (2013)1604 of 12/03/2013
02/03/2016 Transfer of orphan designation EMA/OD/161/12/T/01 (2016)1377 of 29/02/2016